ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Elanco Animal Health Incorporated

Elanco Animal Health Incorporated (ELAN)

23,90
-0,32
(-1,32%)
Beim Schlusskurs: 22 Juni 10:00PM
23,90
0,00
( 0,00% )
Nach Börsenschluss: 10:11PM

Elanco Animal Health Incorporated (ELAN) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
23,90
( -1,32% )
Gebot
-
Fragen
-
Volumen
5.346.700
23,88 Tagesbereich 24,54
13,155 52-Wochen-Bereich 27,72
Marktkapitalisierung
Handelsende
24,22
Handelsbeginn
24,15
Letzte Trade
1
@
23.9
Letzter Handelszeitpunkt
22:10:05
Finanzvolumen
US$ 129.135.161
VWAP
24,1523
Durchschnittliches Volumen (3 Mio.)
US$ 6.052.100
Ausgegebene Aktien
499.449.583
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-47,94
Gewinn pro Aktie (EPS)
-0,49
Erlöse (LTM)
4,89B
Nettogewinn (LTM)
-242M

Über Elanco Animal Health Incorporated

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasi... Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, the company offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana. Mehr anzeigen

Sektor
Healthcare
Branche
Pharmaceuticals
Website
Hauptsitz
Indianapolis, United States
Gegründet
2026
Elanco Animal Health Incorporated is listed in the Healthcare sector of the New York Börse with ticker ELAN. The last closing price for Elanco Animal Health was US$24,22. Over the last year, Elanco Animal Health shares have traded in a share price range of US$ 13,155 to US$ 27,72.

Elanco Animal Health currently has 499.449.583 shares in issue. The market capitalisation of Elanco Animal Health is US$11,94 billion. Elanco Animal Health has a price to earnings ratio (PE ratio) of -47.94.

ELAN Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-1-4.0160642570324.925.0723.15623679124.01643084CS
42.159.8850574712621.7526.2321.63633057223.87648749CS
120.321.3570822731123.5826.2919.4592134222.99914041CS
261.587.0788530465922.3227.7219.4541341723.69578002CS
5210.578.358208955213.427.7213.155587072121.06312148CS
15613.91139.2392392399.9927.728.02536040115.85532707CS
260-11.17-31.850584545235.0737.497.88542709816.90675923CS

ELAN - Frequently Asked Questions (FAQ)

What is the current Elanco Animal Health Incorporated share price?
The current share price of Elanco Animal Health Incorporated is US$ 23,90
How many Elanco Animal Health Incorporated shares are in issue?
Elanco Animal Health Incorporated has 499.449.583 shares in issue
What is the market cap of Elanco Animal Health Incorporated?
The market capitalisation of Elanco Animal Health Incorporated is USD 11,94B
What is the 1 year trading range for Elanco Animal Health Incorporated share price?
Elanco Animal Health Incorporated has traded in the range of US$ 13,155 to US$ 27,72 during the past year
What is the PE ratio of Elanco Animal Health Incorporated?
The price to earnings ratio of Elanco Animal Health Incorporated is -47,94
What is the cash to sales ratio of Elanco Animal Health Incorporated?
The cash to sales ratio of Elanco Animal Health Incorporated is 2,39
What is the registered address of Elanco Animal Health Incorporated?
The registered address for Elanco Animal Health Incorporated is 450 Elanco Circle, Indianapolis, Indiana, 46221
What is the Elanco Animal Health Incorporated website address?
The website address for Elanco Animal Health Incorporated is www.elanco.com
Which industry sector does Elanco Animal Health Incorporated operate in?
Elanco Animal Health Incorporated operates in the Pharmaceuticals sector

ELAN Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen